Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
Sell
-75,200
Closed -$1.54M 4141
2020
Q2
$1.54M Hold
75,200
﹤0.01% 2612
2020
Q1
$1.32M Buy
+75,200
New +$2.32M ﹤0.01% 2510
2019
Q4
Sell
-11,500
Closed -$411K 4151
2019
Q3
$411K Sell
11,500
-3,900
-25% -$140K ﹤0.01% 3304
2019
Q2
$539K Buy
+15,400
New +$535K ﹤0.01% 3039
2017
Q2
Sell
-5,300
Closed -$217K 3528
2017
Q1
$217K Buy
+5,300
New +$221K ﹤0.01% 3090

Other funds holding SNV

D.E. Shaw & Co's SNV Position: Q1 2026 in Review

D.E. Shaw & Co sold out of Synovus (SNV) in Q1 2026, closing a stake of 675,464 shares — an estimated $33.8M sold.

D.E. Shaw & Co first reported a position in SNV in Q2 2013 and held it in 42 quarters. The position peaked at $47.8M in Q3 2025. 1 fund tracked by Wall St. Rank holds SNV as of Q1 2026.

  • D.E. Shaw & Co reported no remaining Synovus position as of Q1 2026 after selling out during the quarter.
  • D.E. Shaw & Co sold 675,464 Synovus shares in Q1 2026, an estimated $33.8M.
  • D.E. Shaw & Co first reported a position in Synovus in Q2 2013 and held it in 42 quarters.
  • D.E. Shaw & Co's Synovus position peaked at $47.8M in Q3 2025.
  • 1 fund tracked by Wall St. Rank held Synovus as of Q1 2026.

Based on D.E. Shaw & Co's 13F filing for Q1 2026, filed 15 May 2026.